Chenglong Liu

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. ncbi request reprint Impacts of HIV infection and HAART use on quality of life
    Chenglong Liu
    Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe Street, Baltimore, MD 21205, USA
    Qual Life Res 15:941-9. 2006
  2. ncbi request reprint Predictors for lower quality of life in the HAART era among HIV-infected men
    Chenglong Liu
    Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 42:470-7. 2006
  3. ncbi request reprint Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection
    Chenglong Liu
    School of Public Health, University of California, Los Angeles, CA 90095, USA
    J Infect Dis 187:1404-10. 2003
  4. ncbi request reprint Persistent GB virus C infection and survival in HIV-infected men
    Carolyn F Williams
    Epidemiology Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
    N Engl J Med 350:981-90. 2004
  5. ncbi request reprint Lack of associations between HLA class II alleles and resistance to HIV-1 infection among white, non-Hispanic homosexual men
    Chenglong Liu
    School of Public Health, University of California, Los Angeles, CA 90095 1772, USA
    J Acquir Immune Defic Syndr 37:1313-7. 2004
  6. doi request reprint Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study
    Chenglong Liu
    J Altern Complement Med 13:1053-6. 2007

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Impacts of HIV infection and HAART use on quality of life
    Chenglong Liu
    Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe Street, Baltimore, MD 21205, USA
    Qual Life Res 15:941-9. 2006
    ..Changes in QOL related to the use of highly active antiretroviral therapy (HAART) have been inconsistent and it is unknown how QOL after HAART compares to pre-infection levels...
  2. ncbi request reprint Predictors for lower quality of life in the HAART era among HIV-infected men
    Chenglong Liu
    Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 42:470-7. 2006
    ..Modifiable determinants of lower QOL should be identified for interventions specifically targeted to the HAART-using individuals to improve their QOL...
  3. ncbi request reprint Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection
    Chenglong Liu
    School of Public Health, University of California, Los Angeles, CA 90095, USA
    J Infect Dis 187:1404-10. 2003
    ..In multivariate logistic analysis, only the A*0205 subgroup (OR, 5.56; 95% CI, 1.34-23.10; P=.018) and the TAP2 Ala665 (OR, 2.22; 95% CI, 1.28-3.84; P=.005) were associated with resistance...
  4. ncbi request reprint Persistent GB virus C infection and survival in HIV-infected men
    Carolyn F Williams
    Epidemiology Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
    N Engl J Med 350:981-90. 2004
    ..Previous studies did not control for differences in the duration of HIV or GBV-C infection...
  5. ncbi request reprint Lack of associations between HLA class II alleles and resistance to HIV-1 infection among white, non-Hispanic homosexual men
    Chenglong Liu
    School of Public Health, University of California, Los Angeles, CA 90095 1772, USA
    J Acquir Immune Defic Syndr 37:1313-7. 2004
    ..Other genetic factors in the HLA class II-TAP region of the major histocompatibility complex might be involved...
  6. doi request reprint Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study
    Chenglong Liu
    J Altern Complement Med 13:1053-6. 2007